The first Regeneron Pharmaceuticals trade was made in Q2 2014.
Since then Mario Gabelli bought shares one more times and sold shares on nine occasions. The investor completely sold their stake between Q3 2017 and Q4 2017.
Avg closing price
Price range
Sold -482 shares
Q4 2017
Avg closing price
$405.00
Price range
$358.63
-
$469.95
Sold 2.0% shares (-10 shares)
Q3 2017
Avg closing price
$475.84
Price range
$431.38
-
$521.22
New holding (+492 shares)
Q2 2017
Avg closing price
$437.61
Price range
$366.06
-
$526.53
Sold -529 shares
Q4 2016
Avg closing price
$380.27
Price range
$336.01
-
$444.52
Sold 60.2% shares (-800 shares)
Q3 2016
Avg closing price
$401.14
Price range
$358.50
-
$441.37
Sold 1.0% shares (-14 shares)
Q2 2016
Avg closing price
$385.12
Price range
$331.05
-
$427.20
Sold 2.5% shares (-35 shares)
Q1 2016
Avg closing price
$412.07
Price range
$359.68
-
$519.48
Sold 35.8% shares (-767 shares)
Q4 2015
Avg closing price
$541.81
Price range
$459.82
-
$587.09
Sold 2.1% shares (-45 shares)
Q2 2015
Avg closing price
$488.02
Price range
$438.27
-
$539.40
Sold 4.6% shares (-105 shares)
Q3 2014
Avg closing price
$335.34
Price range
$296.41
-
$364.41
New holding (+2.3 Thousand shares)
Q2 2014
Avg closing price
$296.38
Price range
$277.29
-
$313.74
News about Regeneron Pharmaceuticals, Inc. and Mario Gabelli